The University of Chicago’s Polsky Center runs two cohorts of its I-Corps Program during the academic calendar year. Each cohort presents at the Collaboratorium, pictured here.
More than 20 teams participated in the Polsky Center I-Corps program this academic year – all with new research and ideas addressing challenges across various industries.
The goal of the eight-week program is to help scientists, researchers, and students test the commercial potential of their research and ideas.
Supported with funding from the National Science Foundation (NSF) through the Great Lakes Region I-Corps Hub, and run by the Polsky Center for Entrepreneurship and Innovation, the program is designed for participants working on projects related to the STEM fields.
I-Corps provides participants with opportunities to expand their network and gain insight from industry stakeholders on the commercialization pathway, identify potential partners for future technical and business development, and receive individualized coaching.
Participants also work to access additional NSF funding, including a potential $50,000 through the National I-Corps program, prepare for SBIR/STTR or other commercialization grants, and engage with other programs at the Polsky Center.
C+UP // C+UP’s breakthrough carbon capture technology converts CO2 from industrial processes/storage into sustainable, carbon-negative eFuels and eChemicals using renewable electricity.
CardiaSpike // The team is developing a functional cardiac tissue patch for surgical applications using 3D bioprinting and spheroid vascularization techniques.
Diamond Stacks // Diamond Stacks seeks to manufacture diamond-integrated wafers for the semiconductor and quantum industries.
Exactics // Exactics has developed a patented, rapid, over-the-counter at-home immunoassay test for the presence of Lyme disease in a sample that shows results within minutes.
IdeaSync // IdeaSync aims to foster healthcare and biomedical innovation by developing a network to support and manage startups emanating from universities.
Molecular Intelligence // The team is providing solutions for the physical modeling of molecular systems to industry partners based on modern AI technology.
Pharos Aerospace // The team will deploy in-space surveillance satellite systems designated to escort satellite constellations and independent operators with optical imaging.
PI-CHAI // PI-CHAI provides AI-assisted prostate cancer diagnosis, combining computer vision with human-centered machine learning technology.
QubitConnect // The team has developed an interconnectable quantum processor that can form larger quantum systems, allowing for secure communication.
Slideflow Labs // Slideflow Labs’ technologies enable low-cost, local deployment of AI pathology biomarkers, addressing the high costs and accessibility barriers of current diagnostics and competing solutions.
Ultra-hard Crystal Slicing // The team utilizes a controlled spalling technique to reuse and repurpose semiconductor substrates, enabling greater adoption of new and promising semiconductor materials systems to address the needs of modern electronics and information technology.
Aquora Biosystems // Aquora’s patented biomembrane filtration technology responds to the market need for low-cost and high throughput filtration of waste streams, spanning municipal wastewater to cow manure.
Bocaliner // Bocaliner is an FDA-registered Class 1 medical device that is designed to enhance the efficacy of oral topical medications.
Good Fibes // Good Fibes is a women-founded textile biotechnology startup providing next-gen protein-based, high-performance fibers to textile manufacturers.
Helix Earth Technologies // The team’s novel, patented filtration technology enables low-pressure-drop (< 100 Pa), high-rate CO2 capture using droplets of aerosolized liquid amines (< 30 µm). These filters make possible high-rate, compact CO2 capture.
Improved biomarkers for TB // This project leverages Epigenetics as the layer of perturbations induced from the disease for a way to decipher and create diagnostics, which can lead to earlier diagnosis without disease symptoms in most vulnerable populations, such as people with HIV and other immunocompromised states.
Ingenii // Ingenii’s QML product is an end-to-end solution designed to revolutionize the drug discovery pipeline. It exploits the power of quantum computing and machine learning, facilitating quantum image pre-processing to refine data quality, and employing tensor networks to compress neural networks.
Marinas Bio // Marinas Bio employs cellular agriculture to produce genuine seafood delicacies, which otherwise lack production efficiency, for the health of people and ecosystems.
Rivalia Chemical // Rivalia harvests rare earth from ash and then transforms the residual ash for use in green concrete.
Valjuvant Vaccines // The team is using immunomodulators as secondary effectors to fine-tune the immune response. We have two goals for this: to reduce inflammation/negative side effects of vaccines, and to improve their durability and efficacy.
Virtual Patient Simulator // This technology can help predict the response to drug and device treatment in the field of cardiology and heart failure. It can also be applied to drug delivery pumps and mechanical heart pumps to tailor therapy for a given patient.
X-Seed Plants // By using genome editing techniques, the team intends to engineer male sterile crops across diverse genetic backgrounds and varieties. The resultant male-sterile crops can then be directly employed for the production of commercially viable hybrid F1 seeds.
Teams including faculty, students, staff, and alumni from the University of Chicago, Argonne National Laboratory, Fermilab, the Marine Biological Laboratory, and Chicago-area universities may apply for the program. No previous business or entrepreneurship experience is required.
Questions? Contact Ellen Zatkowski at ellen.zatkowski@chicagobooth.edu.
Addresses
5807 S. Woodlawn Ave., Ste. 207
Chicago, IL 60637
773.834.4525
1452 E. 53rd St., 2nd Floor
Chicago, IL 60615
773.702.2076
6054 S. Drexel Ave., Ste. 405
Chicago IL 60637
773.702.1692
1463 E. 53rd St., 2nd Floor
Chicago, IL 60615
773.702.2952
© 2024 The University of Chicago.
All rights reserved.
Designed and developed by:
bright bright great
This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.
